Hence, sclerostin should be further evaluated as a pharmaceutical target for osteoarthritis treatment in the case of abnormal loading patterns experienced by patients on long-term bed rest or astronauts on long-term space missions. The gene discussed is SOST; the disease is osteoarthritis.